Astellas Pharma US

Related Content

News | Heart Failure
FDA Approves Digital Health Solution for Heart Failure Management

Sept. 18, 2024 – Astellas Pharma Inc. recently announced that Digitiva, a non-invasive digital health solution for heart ...

Home September 19, 2024
arrow
Technology
Smartphone App Helps Physicians Assess the Need for Radionuclide Imaging

September 28, 2010 – Physicians can now determine whether a patient needs to have cardiac radionuclide imaging (RNI) by ...

Home September 28, 2010
arrow
News
Lexiscan Agent for MPI Meets the Standard

October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine ...

Home October 05, 2009
arrow
Technology
Astellas Launches New Stress Agent for Radionuclide MPI

June 25, 2008 - Lexiscan (regadenoson) injection, an A2A adenosine receptor agonist, for use as a pharmacologic stress ...

Home June 23, 2008
arrow
News
Injection Converts Short-Duration Afib into Sinus Rhythm

March 25, 2008 - Investigational agent KYNAPID (vernakalant hydrochloride) Injection converted short-duration atrial ...

Home March 24, 2008
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now